Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 2,140.30
+26.90 (1.27%)
Jun 13, 2025, 3:29 PM IST
Caplin Point Laboratories Revenue
In the fiscal year ending March 31, 2025, Caplin Point Laboratories had annual revenue of 19.37B INR with 14.23% growth. Caplin Point Laboratories had revenue of 5.02B in the quarter ending March 31, 2025, with 10.37% growth.
Revenue
19.37B
Revenue Growth
+14.23%
P/S Ratio
8.40
Revenue / Employee
5.69M
Employees
3,406
Market Cap
162.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19.37B | 2.41B | 14.23% |
| Mar 31, 2024 | 16.96B | 2.28B | 15.51% |
| Mar 31, 2023 | 14.68B | 1.97B | 15.53% |
| Mar 31, 2022 | 12.71B | 2.09B | 19.64% |
| Mar 31, 2021 | 10.62B | 1.98B | 22.96% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Caplin Point Laboratories News
- 11 days ago - Caplin Point subsidiary to acquire Mexican pharma firm Triwin Pharma S.A. DE C.V. - Business Upturn
- 4 weeks ago - Caplin Point Q4 results: Revenue up 10.9% YoY to Rs 502.45 crore, Net profit rises 19.8% YoY - Business Upturn
- 4 weeks ago - Caplin Point Laboratories subsidiary receives USFDA approval for Haloperidol Decanoate Injection - Business Upturn
- 7 weeks ago - Caplin Point subsidiary Caplin Steriles gets USFDA approval for Phytonadione Injectable Emulsion - Business Upturn
- 2 months ago - Caplin Point Laboratories shares jump over 3% after acquiring Neoethicals Chile SpA - Business Upturn
- 3 months ago - Caplin Point subsidiary secures USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution - Business Upturn
- 4 months ago - Caplin Point Laboratories Q3 FY25 Results: Revenue up 13% YoY to Rs 493 crore, Net Profit up 17% YoY - Business Upturn
- 4 months ago - Caplin Point Laboratories subsidiary secures USFDA approval for Procainamide Hydrochloride Injection - Business Upturn